Abbott seals another companion Dx deal; J&J revamps Ethicon arm;

@FierceMedDev: Combat Medical Systems wins $86M govt. contract. Story | Follow @FierceMedDev

@MarkHFierce: Dx development for the developing world is a hot new area, and the U.K.'s Lumora is diving in. More | Follow @MarkHFierce

 @DamianFierce:  Abbott won FDA approval for a new eye implant, part of its efforts to boost sluggish medical device sales. News | Follow @DamianFierce

> Abbott Laboratories ($ABT) has signed a deal to develop companion diagnostics for Epizyme's investigational cancer drug EPZ-5676. News

> Life Technologies ($LIFE) is partnering with Germany's Ridom to use the company's SeqSphere+ whole genome bacterial typing software with its Ion Torrent sequencers. More

> Cook Medical has launched the Retracta Detachable Embolization Coil, designed to help physicians safely block or slow arterial blood flow. Release

> Thermo Fisher ($TMO) has launched NextGuard, its latest X-ray contamination detector. Item

> Johnson & Johnson ($JNJ) is folding its Ethicon and Ethicon Endo-Surgery subsidiaries into one another, from now on doing business under just the Ethicon moniker. News

> As Israel's medical device market continues to grow, expect more M&A, one analyst says. Article

> Good Start Genetics presented clinical data this week showing that the company's next-generation sequencing tech detects cystic fibrosis and other mutations that conventional technology would otherwise miss. Release

> Abiomed ($ABMD) says its preliminary revenue for the quarter ending March 31 jumped by double-digits compared to last year. Story

Biotech News

@FierceBiotech: GlaxoSmithKline picks up FDA panel plug for Breo approval. Story | Follow @FierceBiotech

@RyanMFierce: S. Korean biotech Celltrion "drops" late-stage Rituxan biosim. Can you imagine this happening w/ a s. molecule? Nope. Report | Follow @RyanMFierce

> Abbott aids biotech Epizyme in matching epigenetic drug with cancer patients. More

> Roche sees another Rituxan biosimilar trial bite the dust. Article

> Antibiotics upstart Allecra snags €15M VC round amid superbug scare. More

Pharma News

@FiercePharma: Baxter to put $300M into old Genmab plant in Minnesota. More | Follow @FiercePharma

@EricPFierce: Is your company among the top 10 pharma companies by employees? If so, where does it fall? Story | Follow @EricPFierce

> Safety watchdog flags GLP-1 drugs for pancreatitis reports to FDA. News

> Will Brazil grab the emerging-markets popularity crown? More

> Sanofi embarks on doc-training in Morocco to boost diabetes, epilepsy care. Article

Vaccines News

> H7N9 cases jump, some show resistance to Roche's Tamiflu. More

> Polio eradication push nearing endgame again. Story

> ITS eyes Big Pharma suitors as universal flu vaccine advances. Article

> India's Biological E pentavalent vaccine takes on GSK, J&J. Item

> Vaccine campaign struggling to contain measles outbreak. More

Pharma Manufacturing News

> Issues with contractor leads to shortage of GSK's Horizant. More

> Sanofi expands in Morocco with €20M hub. News

> Canada's Pharmascience opens new distribution center. Story

> Hikma will keep injectables manufacturing. More

> Contaminated capsules dissolve Biostar earnings. Article

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.